ORAL PEPTIDES
SLU-PP-332 (Oral)
ERR-pan-agonist research compound. 60-count oral capsule bottle.
Bundle & save
Free shipment protection · Overnight shipping available · Ships from our Naples, FL facility
Free shipping
on orders over $150
Damage protection
replacement guarantee
Secure checkout
256-bit SSL
Certificate of Analysis
Third-party tested · ISO/IEC 17025 accredited
99%
purity
✓ Passed full QC panel
- Variant
- SLU-PP-332 (Oral) · 60 caps · 1 mg
- Lot #
- AML-2026-0531
- Labeled
- 60 caps · 1 mg
- Tested
- 2026-04-30
Full QC panel
- Purity (HPLC)
- 99%
- Net Peptide Content
- Pass
- Identity (HPLC-MS)
- Confirmed
- Heavy Metals (ICP-MS)
- Not detected
- Sterility
- No growth
- Endotoxin (LAL)
- Within limits
Purity, lot and tested date are per-lot; remaining QC rows are representative — exact values on the CoA.
Compound Information
Chemical and structural properties
Chemical identity verified via NIH PubChem · biological targets characterized from the peer-reviewed literature.
Molecular profile
Structure
- CAS Number
- 303760-60-3
- Molecular Formula
- C18H14N2O2
- Molecular Weight
- 290.3 g/mol
- Sequence
- (small molecule)
- Type
- Research peptide
- PubChem
- CID 5338394 ↗
Biological targets
Interactions
- Primary target
- Estrogen-related receptors (ERRα / β / γ)
- Pathway
- ERR pan-agonism; mitochondrial biogenesis; fatty-acid oxidation
- Mechanism
- Synthetic ERR pan-agonist studied as an exercise mimetic
- Research area
- Metabolic and mitochondrial research
Physical properties
Handling & Storage
- Appearance
- Off-white to pale solid (small molecule)
- Solubility
- Soluble in DMSO; limited aqueous solubility
- Storage
- Room temp, dry, protect from light
- Country of origin
- USA
Sources & References
Peer-reviewed research
Indexed in NIH PubMed. Provided for research context; not a claim of clinical outcome.
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
A Synthetic ERR Agonist Alleviates Metabolic Syndrome
2024 · PMID 37739806
Billon C et al.
View Source ↗THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity
2026 · PMID 41421047
Billon C et al.
View Source ↗ACS CHEMICAL BIOLOGY
Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity
2023 · PMID 36988910
Billon C et al.
View Source ↗THE AMERICAN JOURNAL OF PATHOLOGY
Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney
2023 · PMID 37717940
Wang XX et al.
View Source ↗CIRCULATION
Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function
2024 · PMID 37961903
Xu W et al.
View Source ↗
⚠ Important research notice
PRODUCTS ARE INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly prohibited by law. Products should only be handled by licensed, qualified professionals. Products sold are not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.
All the research peptides you need, with the peace of mind at your fingertips.
Research updates from Aminologix
Catalog updates, new research compounds, and quality-documentation news. For researchers and labs. No spam, unsubscribe anytime.